La anemia hemolítica autoinmune (AHAI) es una enfermedad poco frecuente en la edad pediátrica. Su diagnóstico se establece mediante la prueba de. La asociación de colitis ulcerosa (CU) y anemia hemolítica autoimmune (AHAI) se describió por primera vez a principios de la década de los cincuenta; sin. Se estudiaron 13 pacientes con leucemia mieloide crónica y anemia hemolítica autoinmune inducida por el interferón alfa, a quienes se les realizó la detección.

Author: Fekazahn Tajora
Country: Tanzania
Language: English (Spanish)
Genre: Art
Published (Last): 2 October 2010
Pages: 472
PDF File Size: 15.13 Mb
ePub File Size: 5.95 Mb
ISBN: 699-4-33592-950-2
Downloads: 83897
Price: Free* [*Free Regsitration Required]
Uploader: Yozshujas

Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: Inmunologia celular y molecular. Correlation between in vivo hemolysis and the amount of red cell-bound IgG measured by flow cytometry.

To improve our services and products, we use “cookies” own or third parties authorized to show aneima related to client preferences through the analyses of navigation customer behavior.

It was detected the presence of IgG and C3 in A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab hemolitida patients with autoimmune haemolytic anaemia.

Blood,pp. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

Rituximab in refractory autoimmune hemolytic anemia in systemic lupus erythematosus. In high-grade hemolysis patients, it was found a concentration of autoantibodies between 1 and 3 molecules of IgG per erythrocyte, while in low-grade hemolysis snemia it behaved between and 1 molecules.


July – August Pages CiteScore measures average citations received per document published. Rev Cubana Hematol Inmunol Hemoter. Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukemia.

This item has received. Jonasch E, Haluska FG. Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.

Best Pract Res Clin Haematol. Are you a health professional able to heolitica or dispense drugs? Treatment of AIHA, especially in cold antibody-mediated disease, represents a therapeutical challenge.

They underwent tests for immune protein detection and characterization of IgG subclasses in RBCs by direct antiglobulin test PAD and the microplate technique.

Anemia Hemolítica Autoinmune | Medical City McKinney

Rev Cubana Hematol Inmunol Hemoter, 29pp. Los andmia de la prueba de antiglobulina directa PAD y de la prueba de antiglobulina indirecta PAI previos al tratamiento con IFN ase obtuvieron de los registros del laboratorio.

Corticoids represent the standard frontline therapeutic option for warm autoantibodies haemolytic anaemia. Lupus, 24pp. Pediatd Hematol Oncol, 20pp. The role of rituximab in adults with warm antibody autoimmune hemolytic anaemia.

There was a problem providing the content you requested

In 11 patients the presence of IgG1 was showed and also in one case the subclass IgG3 autoantibodies was identified.


Recently, rituximab has been shown to be an alternative treatment option in children as well as in adults for relapsed and refractory autoimmune haemolytic anaemias and in patients who are medically unsuited for espenectomy.

Key words autoimmune haemolytic anaemia, cold agglutinin disease, rituximab. En todos los pacientes, el tratamiento con IFN a fue suspendido al demostrarse la presencia de autoanticuerpos eritrocitarios.

Published studies are primarily clinical and epidemiological research but also basic. Ann Hematol, 89pp. Lower dose of rituximab in the treatment of elderly autoinmune hemolytic anemia.

Haemolytic anemia to the alpha interferon treatment: SRJ is a prestige metric based on the idea that not all citations are the same. Therefore, properly designed clinical trials evaluating rituximab as salvage- and first-line-therapy for the treatment of AIHA and cold agglutinin disease are clearly warranted.

Raanani P, Ben-Bassat I. Autoinmune hemolytic anemia during interferon treatment in nine patients with hematological diseases.

ApartadoCP The mechanism of action appears to be linked with the selective B-cell depletion and the lowering of autoantibody levels.